BSX Q4 2024 Earnings — Boston Scientific Corporation Revenue & Financial Results | Market Cap Arena

BSXBoston Scientific Corporation

$105B

Q4 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$4.6B+22.4% YoY

Gross Profit

$2.7B58.6% margin

Operating Income

$589M12.9% margin

Net Income

$566M12.4% margin

EPS (Diluted)

$0.38

QoQ Revenue Growth

+8.4%

Cash Flow

Operating Cash Flow

$1.5B

Free Cash Flow

$1.2B

Stock-Based Comp.

$69M

Balance Sheet

Total Assets

$39.4B

Total Liabilities

$17.4B

Stockholders' Equity

$21.8B

Cash & Equivalents

$414M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4.6B	$3.7B	+22.4%
Gross Profit	$2.7B	$2.3B	+15.5%
Operating Income	$589M	$558M	+5.6%
Net Income	$566M	$504M	+12.3%

Revenue Segments

Cardiovascular

$2.9B65%

MedSurg

$1.6B35%

Geographic Segments

UNITED STATES

$2.9B63%

Non-US

$1.7B37%